2009•Strait Pharmaceutical JournalRequires access

Studies on bioequivalence of two nimodipine tablets in healthy volunteers by HPLC-MS

Zou Jiang-jun

Open publisher page 0 citations

Abstract

OBJECTIVE To evaluate the bioequivalence of two domestic nimodipine tablets.METHODS A single oral administration of 60mg nimodipine tablet was given to 20 healthy volunteers.Nimodipine concentrations in plasma were determined by HPLC-MS.RESULTS The main pharmacokinetic parameters of two nimodipine tablets were as follow:t1/2 was(2.1±0.3) and(2.2±0.4)h,tmax was(1.5±0.4) and(1.6±0.4)h,cmax was(28.21±7.12) and(28.79±7.56)ng·mL-1,AUC was(105.88±29.49) and(106.46±26.38)μg·h·L-1,respectively.The relative bioavailability of the test tablet was 99.4±5.3%。CONCLUSION The results demonstrated that the two tablets were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE To evaluate the bioequivalence of two domestic nimodipine tablets.METHODS A single oral administration of 60mg nimodipine tablet was given to 20 healthy volunteers.Nimodipine concentrations in plasma were determined by HPLC-MS.RESULTS The main pharmacokinetic parameters of two nimodipine tablets were as follow:t1/2 was(2.1±0.3) and(2.2±0.4)h,tmax was(1.5±0.4) and(1.6±0.4)h,cmax was(28.21±7.12) and(28.79±7.56)ng·mL-1,AUC was(105.88±29.49) and(106.46±26.38)μg·h·L-1,respectively.The relative bioavailability of the test tablet was 99.4±5.3%。CONCLUSION The results demonstrated that the two tablets were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To evaluate the bioequivalence of two domestic nimodipine tablets.METHODS A single oral administration of 60mg nimodipine tablet was given to 20 healthy volunteers.Nimodipine concentrations in plasma were determined by HPLC-MS.RESULTS The main pharmacokinetic parameters of two nimodipine tablets were as follow:t1/2 was(2.1±0.3) and(2.2±0.4)h,tmax was(1.5±0.4) and(1.6±0.4)h,cmax was(28.21±7.12) and(28.79±7.56)ng·mL-1,AUC was(105.88±29.49) and(106.46±26.38)μg·h·L-1,respectively.The relative bioavailability of the test tablet was 99.4±5.3%。CONCLUSION The results demonstrated that the two tablets were bioequivalent.

Key concepts: Bioequivalence, Nimodipine, Cmax, Bioavailability, Pharmacokinetics, Pharmacology, High-performance liquid chromatography, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Studies on bioequivalence of two nimodipine tablets in healthy volunteers by HPLC-MS — Research Paper | ScholarLens